The landscape of morphine across Europe is surprisingly uneven, governed by a collection of national policies and EU directives. While morphine sulphate remains an critical medication for severe pain management, its prescription is tightly controlled. Generally, receipt is restricted to specialist physicians, often requiring specific permits and… Read More

While ketamine has shown promise as a treatment for severe depression, its availability differs significantly across Australia. At present, ketamine therapy is primarily offered in specialized clinics and hospitals, often with a focus on patients who haven't benefited from traditional antidepressant medications. The regulatory landscape persists… Read More